TKT management additions
Executive Summary
Former Biogen VP-Development & Quality David Pendergast, PhD, is appointed TKT senior VP-quality & analytical development, replacing VP Joseph Habarta, PhD. Pendergast reports to CEO Richard Selden, MD/PhD. At Biogen, Pendergast is replaced by Sylvie Gregoire, who is promoted to exec VP-technical operations. Another Biogen alum and former Vertex Program Executive Neil Kirby, PhD, joins TKT as VP-global regulatory affairs, replacing Kurt Gunter, MD. Kirby reports to General Counsel Michael Astrue...